This downregulation leads to the enhanced activation of the anchorage-independent growth, migration, and invasion of NSCLC cells, partially through activation of EMT via the NFκB/SNAI1/YY1/Raf kinase inhibitor protein (RKIP) signaling pathway [410]. The gene discussed is PEBP1; the disease is non-small cell lung carcinoma.